Login
Enter your username or email address
Enter the password that accompanies your username.

Request new password

Home

Progress in Mind Middle East and Africa

  • Topics
    • COVID-19 Pandemic
    • Alcohol Dependance
    • Alzheimer's Disease
    • Bipolar Disease
    • Depression
    • Schizophrenia
    • Parkinson's Disease
    • Migraine
  • Congress highlights
    • ECNP 2022
    • ASUIP 2022
    • EAN 2022
    • COVID-19 MEA
    • ECNP 2021
    • EAN 2021
    • APA 2019
  • Expert Views
  • Podcast
  • About Us

The information on this site is exclusively intented for health care professionals.

ACCEPT DECLINE
Schizophrenia 25 Sep, 2019

Video #6: Which patients are best suited for long-acting injectable antipsychotics?

 Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment?

Sign up for Progress in Mind Middle East and Africa

Sign up for our newsletter and stay updated on new content and resources.

Related

Bipolar
Article

Managing the burdens of bipolar disorder

Schizophrenia
Article

Future of schizophrenia treatment: Where do we go now?

Alzheimer's Disease
Article

New insights into Apolipoprotein E and Alzheimer’s Disease

Social Networks

Progress in Mind Middle East and Africa HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Middle East and Africa click here.

Register Already registered

Brought to you by

 Lundbeck

© 2022 Lundbeck Middle East and Africa

PROGRESS IN MIND MIDDLE EAST & AFRICA

Cookies

Privacy Information and Disclaimer

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue